TELA BIO INC's ticker is TELA and the CUSIP is 872381108. A total of 55 filers reported holding TELA BIO INC in Q1 2023. The put-call ratio across all filers is 2.83 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,094,680 | -21.9% | 136,835 | -1.2% | 0.00% | – |
| Q2 2023 | $1,402,367 | +537.0% | 138,437 | +569.1% | 0.00% | – |
| Q1 2023 | $220,152 | +2.7% | 20,691 | +11.0% | 0.00% | – |
| Q4 2022 | $214,383 | +84.8% | 18,642 | +37.3% | 0.00% | – |
| Q3 2022 | $116,000 | +18.4% | 13,576 | -3.0% | 0.00% | – |
| Q2 2022 | $98,000 | -43.4% | 13,994 | -6.2% | 0.00% | – |
| Q1 2022 | $173,000 | -9.4% | 14,912 | 0.0% | 0.00% | – |
| Q4 2021 | $191,000 | -6.4% | 14,912 | 0.0% | 0.00% | – |
| Q3 2021 | $204,000 | -7.7% | 14,912 | +8.7% | 0.00% | – |
| Q2 2021 | $221,000 | -80.4% | 13,716 | -81.9% | 0.00% | – |
| Q1 2021 | $1,130,000 | -2.2% | 75,839 | -1.3% | 0.00% | – |
| Q4 2020 | $1,156,000 | -12.5% | 76,871 | -3.7% | 0.00% | – |
| Q3 2020 | $1,321,000 | +441.4% | 79,838 | +324.3% | 0.00% | – |
| Q2 2020 | $244,000 | +82.1% | 18,815 | +81.8% | 0.00% | – |
| Q4 2019 | $134,000 | – | 10,348 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 3,565,709 | $24,996,000 | 10.33% |
| Opaleye Management Inc. | 1,643,367 | $11,520,000 | 5.19% |
| INDUSTRY VENTURES, L.L.C. | 579,745 | $4,064,000 | 4.31% |
| Velan Capital Investment Management LP | 498,238 | $3,493,000 | 3.54% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 116,095 | $825,000 | 0.83% |
| HAMILTON LANE ADVISORS LLC | 264,366 | $1,853,000 | 0.72% |
| AIGH Capital Management LLC | 306,464 | $2,156,000 | 0.57% |
| Worth Venture Partners, LLC | 113,012 | $904,000 | 0.53% |
| Granite Point Capital Management, L.P. | 227,644 | $1,596,000 | 0.41% |
| Orbimed Advisors | 3,027,542 | $21,223,000 | 0.38% |